Hamilton Thorne (TSE:HTL) has released an update.
Hamilton Thorne Ltd has secured shareholder approval for its ‘going private’ transaction, with over 99.98% support from voting shareholders, excluding certain minority votes. The company, a leader in Assisted Reproductive Technologies (ART), also announced imminent finalization of its acquisition of Cook Medical’s ART portfolio and expected regulatory clearances, anticipating the deal’s closure in Q4 2024. Post-transaction, Hamilton Thorne will be delisted from the TSX and will stop being a reporting issuer in Canada.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.
